President Trump has got plenty of ideas about how he’ll address national debt: He’ll pay it down through tariffs, or offset some of the borrowing thanks to proceeds from his “golden visa” program. He’s also said he’ll rebalance the debt-to-GDP ratio by growing the economy, and would reduce the need for as much borrowing thanks to initiatives like the Department …
Read More »Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook CNBC Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop Investor’s Business Daily Merck to Lay Off Workers and Narrows Guidance as Earnings Fall – WSJ The Wall Street Journal Our Q2 2025 financial results Merck.com …
Read More »
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. Sarepta Therapeutics laid off more than one-third of its workforce, …
Read More »